TC BioPharm $TCBP Announces Submission of Investigational New Drug (IND) Application to U.S. FDA for Treatment of Relapse/Refractory AML https://ir.tcbiopharm.com/news/press-releases/detail/64/tc-biopharm-announces-submission-of-investigational-new